Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$35.55 - $43.57 $1.73 Million - $2.12 Million
-48,554 Reduced 11.26%
382,635 $16.6 Million
Q3 2023

Nov 13, 2023

SELL
$39.13 - $47.24 $6.71 Million - $8.1 Million
-171,387 Reduced 28.44%
431,189 $17.5 Million
Q2 2023

Aug 14, 2023

BUY
$43.93 - $46.76 $3.7 Million - $3.94 Million
84,320 Added 16.27%
602,576 $27.1 Million
Q1 2023

May 15, 2023

BUY
$45.29 - $50.76 $23 Million - $25.7 Million
506,880 Added 4455.7%
518,256 $23.8 Million
Q4 2022

Feb 14, 2023

SELL
$41.91 - $50.48 $23.1 Million - $27.8 Million
-551,497 Reduced 97.98%
11,376 $567,000
Q3 2022

Nov 14, 2022

BUY
$40.9 - $50.42 $17 Million - $20.9 Million
414,937 Added 280.48%
562,873 $23.2 Million
Q2 2022

Aug 15, 2022

BUY
$42.98 - $49.77 $4.93 Million - $5.71 Million
114,724 Added 345.43%
147,936 $6.98 Million
Q1 2022

May 09, 2022

SELL
$42.23 - $54.3 $6.38 Million - $8.2 Million
-151,084 Reduced 81.98%
33,212 $1.63 Million
Q4 2021

Feb 01, 2022

BUY
$50.62 - $56.47 $9.33 Million - $10.4 Million
184,296 New
184,296 $10.2 Million
Q3 2021

Nov 12, 2021

SELL
$46.55 - $56.83 $2.06 Million - $2.51 Million
-44,218 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$46.28 - $52.75 $230,752 - $263,011
4,986 Added 12.71%
44,218 $2.14 Million
Q1 2021

May 14, 2021

BUY
$46.25 - $56.02 $1.81 Million - $2.2 Million
39,232 New
39,232 $1.91 Million
Q4 2020

Feb 16, 2021

SELL
$46.09 - $54.74 $2.14 Million - $2.55 Million
-46,510 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$42.51 - $52.42 $7.59 Million - $9.36 Million
-178,532 Reduced 79.33%
46,510 $2.43 Million
Q2 2020

Aug 14, 2020

BUY
$39.49 - $44.36 $8.38 Million - $9.41 Million
212,183 Added 1650.07%
225,042 $9.63 Million
Q1 2020

May 15, 2020

BUY
$33.17 - $41.6 $426,533 - $534,934
12,859 New
12,859 $535,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $9.16B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.